Genetic polymorphisms of purinergic P2Y2 receptor were associated with the susceptibility to essential hypertension in Chinese postmenopausal women-Reference-Cited by-同舟云学术

Genetic polymorphisms of purinergic P2Y2 receptor were associated with the susceptibility to essential hypertension in Chinese postmenopausal women

Published:2023-01-19 Issue:4 Volume:19 Page:663-671
ISSN:1573-9538
Container-title:Purinergic Signalling
language:en
Short-container-title:Purinergic Signalling

Author:

Li Ao,Xiong Chaopeng,Gong Chengxin,Gou Mengyang,Wang Yaqun,Yang Yuping,Xu Hong

Funder

National Natural Science Foundation of China

“Double Thousand Plan” Science and Technology Innovation High-end Talent Project of Jiangxi Province

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,Molecular Biology

Link

https://link.springer.com/content/pdf/10.1007/s11302-023-09921-6.pdf

Reference45 articles.

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 19:2560–72

2. Whitworth J, Lang D, Henry D (1999) Cost-effectiveness analysis in the treatment of hypertension: a medical view. Clinical and experimental hypertension. Clin Exp Hypertens 21:999–1008

3. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA et al (2002) Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 288:1882–8

4. Wu Y, Huxley R, Li L, Anna V, Xie G, Yao C et al (2008) Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002. Circulation 118:2679–86

5. Chen WW, Gao RL, Liu LS, Zhu ML, Wang W, Wang YJ et al (2017) China cardiovascular diseases report 2015: a summary. J Geriatric Cardiology: JGC 14:1–10